Fox Chase Cancer Center Endowed Chairs

As a pioneer in the area of risk assessment and prevention of breast and ovarian cancer, Mary has saved the lives of many women, changed the practices of health care providers worldwide, and fostered an international revolution in the area of clinical cancer genetics. Whether at the forefront as a dedicated oncologist, a math and science teacher in Kenya, a Lieutenant Colonel in the Air Force, or a female role model, Mary's compassionate ways and exemplary skills leave a lasting impression with whomever she encounters; an invaluable colleague and friend."
— Margie L. Clapper, PhD
Director,
Chemoprevention Research
Co-Leader,
Keystone Program in Personalized Risk and Prevention
Launch the video: Endowed Chairs, a Living, Life-Giving Legacy

Hear from researchers why endowing a chair is so important to Fox Chase Cancer Center research, and to our patients.
See the video (7 min 25 sec)

Fox Chase Cancer Center Endowed Chair Program logoTimothy R. Talbot Jr. Chair in Cancer Research

This chair honors Timothy R. Talbot Jr., MD, the visionary scientific director of the Institute for Cancer Research and the first president of Fox Chase Cancer Center.  This chair was established by Dr. Talbot’s friends and colleagues to recognize and support an outstanding leader in the field of cancer research who represents the highest standards of excellence.

Mary B. Daly, MD, PhD, FACP

Mary B. Daly, MD, PhD, FACP

Chair, Department of Clinical Genetics
Dr. Daly’s focus is in women’s health, and she is the Founding Director of the Margaret Dyson Family Risk Assessment Program, evaluating preventive approaches to breast and ovarian cancer. Her primary areas of research include the epidemiologic and genetic aspects of breast and ovarian cancer, and the translation of this information into effective cancer control approaches. Dr. Daly has initiated studies of ovarian cancer screening modalities, quality of life after prophylactic surgery, serum biomarkers of breast cancer risk.

As Principal Investigator of the Cooperative Family Registry for Breast Cancer Studies, she is collaborating with institutions worldwide to study the patterns of familial breast and ovarian cancer, gene-environment interactions, and the development of novel, genetic-based therapeutic and preventive strategies.

Dr. Daly is the leader of the Keystone Program in Personalized Risk and Prevention. Its goal is to bridge the gap between Fox Chase’s current clinical programs in family risk for cancer and basic prevention research programs to decrease cancer incidence and mortality.

For information about how to support Fox Chase's endowed funds, please contact:


Rich Santoro
Senior Director, Major and Planned Gifts
Institutional Advancement
Fox Chase Cancer Center
333 Cottman Avenue
Philadelphia, PA 19111
Tel: 215-728-3192
Fax: 215-728-2759
rich.santoro@fccc.edu